Back to CVE records
High 7.1Published Apr 7, 2026

CVE-2026-39308PraisonAI is a multi-agent teams system.

Updated under an hour ago ()

Does this affect you?

It affects praisonai. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

PraisonAI is a multi-agent teams system. Prior to 1.5.113, PraisonAI's recipe registry publish endpoint writes uploaded recipe bundles to a filesystem path derived from the bundle's internal manifest.json before it verifies that the manifest name and version match the HTTP route. A malicious publisher can place ../ traversal sequences in the bundle manifest and cause the registry server to create files outside the configured registry root even though the request is ultimately rejected with HTTP 400. This is an arbitrary file write / path traversal issue on the registry host. It affects deployments that expose the recipe registry publish flow. If the registry is intentionally run without a token, any network client that can reach the service can trigger it. If a token is configured, any user with publish access can still exploit it. This vulnerability is fixed in 1.5.113.

CVSS
7.1 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:L
Weakness (CWE)
CWE-22
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
praison praisonai
praison:praisonai
through 4.5.112
NVD

References

  • exploit, mitigation, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.